Your browser doesn't support javascript.
loading
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia.
Caracciolo, Daniele; Riillo, Caterina; Ballerini, Andrea; Gaipa, Giuseppe; Lhermitte, Ludovic; Rossi, Marco; Botta, Cirino; Duroyon, Eugénie; Grillone, Katia; Gallo Cantafio, Maria Eugenia; Buracchi, Chiara; Alampi, Greta; Gulino, Alessandro; Belmonte, Beatrice; Conforti, Francesco; Golino, Gaetanina; Juli, Giada; Altomare, Emanuela; Polerà, Nicoletta; Scionti, Francesca; Arbitrio, Mariamena; Iannone, Michelangelo; Martino, Massimo; Correale, Pierpaolo; Talarico, Gabriella; Ghelli Luserna di Rorà, Andrea; Ferrari, Anna; Concolino, Daniela; Sestito, Simona; Pensabene, Licia; Giordano, Antonio; Hildinger, Markus; Di Martino, Maria Teresa; Martinelli, Giovanni; Tripodo, Claudio; Asnafi, Vahid; Biondi, Andrea; Tagliaferri, Pierosandro; Tassone, Pierfrancesco.
Afiliação
  • Caracciolo D; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Riillo C; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Ballerini A; BiovelocITA srl, Milano, Italy.
  • Gaipa G; Centro Ricerca M. Tettamanti, Clinica Pediatrica Università Milano-Bicocca, Ospedale San Gerardo, Monza, Italy.
  • Lhermitte L; Université de Paris, Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, Paris, France.
  • Rossi M; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
  • Botta C; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Duroyon E; Hematology Unit, Annunziata Hospital, Cosenza, Italy.
  • Grillone K; Université de Paris, Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, Paris, France.
  • Gallo Cantafio ME; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
  • Buracchi C; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Alampi G; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Gulino A; Centro Ricerca M. Tettamanti, Clinica Pediatrica Università Milano-Bicocca, Ospedale San Gerardo, Monza, Italy.
  • Belmonte B; Centro Ricerca M. Tettamanti, Clinica Pediatrica Università Milano-Bicocca, Ospedale San Gerardo, Monza, Italy.
  • Conforti F; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo, Palermo, Italy.
  • Golino G; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo, Palermo, Italy.
  • Juli G; Pathology Unit, Annunziata Hospital, Cosenza, Italy.
  • Altomare E; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Polerà N; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Scionti F; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Arbitrio M; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Iannone M; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Martino M; IRIB-CNR, Catanzaro, Italy.
  • Correale P; IRIB-CNR, Catanzaro, Italy.
  • Talarico G; Stem Cell Transplant Program, Clinical Section, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
  • Ghelli Luserna di Rorà A; Medical Oncology Unit, "Bianchi-Melacrino-Morelli" Grand Metropolitan Hospital, Reggio Calabria, Italy.
  • Ferrari A; Immunotransfusion Service Unit, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
  • Concolino D; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Sestito S; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Pensabene L; Department of Medical and Surgical Sciences, Pediatric Unit, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Giordano A; Department of Medical and Surgical Sciences, Pediatric Unit, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Hildinger M; Department of Medical and Surgical Sciences, Pediatric Unit, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Di Martino MT; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, USA.
  • Martinelli G; Evitria, Zurich, Switzerland.
  • Tripodo C; Department of Experimental and Clinical Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy.
  • Asnafi V; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Biondi A; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo, Palermo, Italy.
  • Tagliaferri P; Université de Paris, Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, Paris, France.
  • Tassone P; Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France.
J Immunother Cancer ; 9(2)2021 02.
Article em En | MEDLINE | ID: mdl-33597219
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Anticorpos Biespecíficos / Leucossialina / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Anticorpos Biespecíficos / Leucossialina / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article